Skip to main content
. Author manuscript; available in PMC: 2014 Apr 1.
Published in final edited form as: Nat Genet. 2013 Aug 25;45(10):1150–1159. doi: 10.1038/ng.2742

Table 1.

Subject characteristics and sample sizes.

Feature Cases Controls
Swedish sample characteristics
 Male sex 0.595 0.512
 Median age at sampling 54 (45-62) 57 (48-65)
 Median hospital admissions for SCZ or SAD 7 (3-15) n/a
 Median total inpatient days 243 (81-696) n/a
 Median years from first to last HDR admission 9.7 (2.9-19.5) n/a
Sample sizes
 Swedish subjects (Sw1-6) 5,001 6,243
 PGC schizophrenia subjects (excluding Sw1-2) 8,832 12,067
 Replication results for up to 168 genomic regions 7,413 19,762
 Total subjects 21,246 38,072

Values in parentheses are inter-quartile ranges. The case group had significantly more males (p < 0.0001) and was significantly younger (p < 0.0001) than controls although these differences were not of large magnitude. The higher median age in controls is in the direction of greater confidence in control classification (i.e., controls had greater time at risk for psychiatric hospitalization). Cases tended to have had considerable hospitalizations, inpatient lengths of stay, and years of observation. IQQ=interquartile range, SCZ=schizophrenia, SAD=schizoaffective disorder, HDR=Hospital Discharge Register.

All cases and controls are independent. The Swedish sample totals N=11,244, the PGC N=20,899, and the replication samples N=27,175. The Sweden plus PGC meta-analysis is based on N=32, 143. The Swedish sample plus PGC plus replication samples total 59,318. (these counts exclude 511 trios).